Pharmacy prevalence of second victim syndrome in a comprehensive cancer center
April 3, 2025
In this podcast, Dr. Tami Johnson and Dr. Anne Tucker discuss the AJHP Practice Research Report, “Pharmacy prevalence of second victim syndrome in a comprehensive cancer center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Tami N. Johnson, Pharm.D., BCPS is a clinical pharmacy specialist in emergency medicine at the University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Johnson earned her Doctor of Pharmacy from the University of Nebraska Medical Center in Omaha, Nebraska. She completed both a PGY1 and PGY2 critical care residencies at St. Luke’s Episcopal Hospital in Houston, Texas. Dr. Johnson has authored and co-authored several publications, including journal articles and book chapters.
Anne Tucker, Pharm.D., BCNSP, FASPEN is a clinical pharmacy specialist in critical care-nutrition support at the University of Texas MD Anderson Cancer Center in Houston, Texas. She received her Doctor of Pharmacy from the University of Arkansas for Medical Sciences, Little Rock, Arkansas, where she also completed residency training. Dr. Tucker is active in the American Society for Parenteral and Enteral Nutrition, where she is a frequent invited presenter, author, and serves on the board of directors.
Daniel J. Cobaugh, Pharm.D., FAACT, DABAT is the senior vice president of professional development and publishing at ASHP and the editor-in-chief of AJHP. He has served on the ASHP staff since 2002. He received his B.S. in Pharmacy from the University of Pittsburgh and his Doctor of Pharmacy from Duquesne University. Cobaugh completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT